IDO1 and melanoma: This hypothesis might be consistent with the frequencies detected for the four SLN LCs subsets in melanoma patients, being CD83+IDO1- and CD83-IDO1- the main SLN LCs subsets, and CD83+IDO1+ SLN LCs, the lower one, slightly affected by melanoma.